Omega Pharma Limited and Galpharm International Limited are recalling all unexpired stock of Ranitidine Tablets (various liveries) from pharmacies and retail stores as a precautionary measure due to possible contamination with an impurity N-nitrosodimethylamine (NDMA) which has genotoxic and carcinogenic potential.
This alert is the second alert, out of two, related to ranitidine products issued today (25 October 2019). This has been issued as a separate alert as it relates to particular ranitidine products that can be supplied without a prescription.
Full details of the drug alert are included in the attached PDF file. Please forward to listed recipients. This information is also published on the MHRA website https://www.gov.uk/drug-device-alerts.